Andrew Garst

This inventor holds 78 USPTO granted patents and 28 published patent applications and 4 EPO patents, primarily in CRISPR Technology (CPC class C12N). Top assignees: Inscripta, Inc., University of Colorado. Active years: 2018-2025.

USPTO Granted Patents = 78 (Patent Applications = 28)

% Patents Active = 98.7

EPO Patents = 4 (Patent Applications = 15)

Average Co-Inventor Count = 3.5

ph-index = 16

Forward Citations = 1,253(Granted Patents)

Forward Citations (Not Self Cited) = 850(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

University of Colorado

patents

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

Areas of Expertise:

CRISPR

Nucleases

Genome Engineering

RNA Aptamers

Detection Methods

Combinatorial Libraries

Engineered Enzymes

Automated Modules

Live Cell Detection

Affinity Tags

Complementation Assays

Barcoded Libraries

78 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12416008 - Compositions and methods of use for small-molecule regulation of CRISPR-Cas9 activity using RNA aptamers (2025-09-16),

2. 12195749 - Nucleic acid-guided nucleases (2025-01-14),

3. 12180502 - Nucleic acid-guided nucleases (2024-12-31),

4. 11795479 - CRISPR enabled multiplexed genome engineering (2023-10-24),

5. 11739290 - Instruments, modules, and methods for improved detection of edited sequences in live cells (2023-08-29),

6. 11702677 - CRISPR enabled multiplexed genome engineering (2023-07-18),

7. 11697826 - Nucleic acid-guided nucleases (2023-07-11),

8. 11685889 - Detection of nuclease edited sequences in automated modules and instruments (2023-06-27),

9. 11639511 - CRISPR enabled multiplexed genome engineering (2023-05-02),

10. 11584928 - Methods for generating barcoded combinatorial libraries (2023-02-21),

11. 11512297 - Affinity tag for recombination protein recruitment (2022-11-29),

12. 11408012 - Nucleic acid-guided nucleases (2022-08-09),

13. 11365383 - Detection of nuclease edited sequences in automated modules and instruments (2022-06-21),

14. 11359187 - Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells (2022-06-14),

15. 11345933 - CRISPR enabled multiplexed genome engineering (2022-05-31),

Title: The Innovative Journey of Andrew Garst

Introduction: Andrew Garst, a talented inventor based in Boulder, CO, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Andrew Garst holds several patents in the areas of artificial intelligence, renewable energy, and sustainable agriculture, showcasing his diverse range of interests and expertise.

Career Highlights: With a background in engineering and a passion for innovation, Andrew Garst has successfully developed and implemented various cutting-edge technologies that have had a positive impact on society. His commitment to pushing the boundaries of what is possible has earned him recognition in the industry.

Collaborations: Throughout his career, Andrew Garst has collaborated with leading research institutions, universities, and tech companies to further his inventions and bring them to market. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Andrew Garst's relentless pursuit of innovation and his dedication to creating solutions for complex challenges make him a standout figure in the world of inventors. His work continues to inspire and shape the future of technology.